Ion Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-896,365
Closed -$6.89M 19
2016
Q2
$6.89M Sell
896,365
-229,316
-20% -$1.63M 3.25% 10
2016
Q1
$8.23M Sell
1,125,681
-77,017
-6% -$552K 3.76% 11
2015
Q4
$9.27M Buy
1,202,698
+707,910
+143% +$5.4M 4.06% 10
2015
Q3
$3.54M Buy
494,788
+66,790
+16% +$642K 4.93% 10
2015
Q2
$4.54M Buy
427,998
+59,227
+16% +$694K 5.31% 8
2015
Q1
$4.57M Sell
368,771
-39,144
-10% -$433K 5.01% 8
2014
Q4
$3.81M Buy
+407,915
New +$3.93M 3.89% 11

Other funds holding ELOS

Ion Asset Management's ELOS Position: Q3 2016 in Review

Ion Asset Management sold out of Syneron Medical Ltd (ELOS) in Q3 2016, closing a stake of 896,365 shares — an estimated $6.89M sold.

Ion Asset Management first reported a position in ELOS in Q4 2014 and held it in 7 quarters. The position peaked at $9.27M in Q4 2015. 65 funds tracked by Wall St. Rank hold ELOS as of Q3 2016.

  • Ion Asset Management reported no remaining Syneron Medical Ltd position as of Q3 2016 after selling out during the quarter.
  • Ion Asset Management sold 896,365 Syneron Medical Ltd shares in Q3 2016, an estimated $6.89M.
  • Ion Asset Management first reported a position in Syneron Medical Ltd in Q4 2014 and held it in 7 quarters.
  • Ion Asset Management's Syneron Medical Ltd position peaked at $9.27M in Q4 2015.
  • 65 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2016.

Based on Ion Asset Management's 13F filing for Q3 2016, filed 15 Nov 2016.